Atlas Trials

Gentamicin for RDEB

Clinical trial NCT03012191 · COMPLETED

Trial details

NCT number
NCT03012191
Sponsor
University of Southern California
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Recessive Dystrophic Epidermolysis Bullosa
Start date
2017-02-02
Primary completion
2018-05-05
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.